Los Angeles, CA – According to filings with the U.S. Securities and Exchange Commission, Sensydia is raising $4,100,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Anthony Arnold played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Sensydia

Sensydia is committed to developing technology for the rapid, non-invasive diagnosis and management of patients with heart disease. Sensydia merged expertise in clinical cardiology, biomedical engineering and machine learning in the development of fast, wireless cardiac function monitoring.

To learn more about Sensydia, visit http://www.sensydia.com/

Contact:
Anthony Arnold, President and Chief Executive Officer
310-593-1967
https://www.linkedin.com/in/akarnold/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved